logo.png
Autonomix Medical, Inc. Successfully Completes Preclinical Safety Study to Support Program Advancement into First-in-Human Clinical Study to Treat Pancreatic Cancer Pain Through Transvascular Ablation
12 janv. 2024 10h00 HE | Autonomix Medical, Inc.
Patented two-fold technology in development to locate, ablate and confirm successful ablation of specific nerves for pain management and other uses All safety inputs met with no reported...